pathology_id stringlengths 19 19 | country stringclasses 7
values | year int64 2.02k 2.03k | facility_type stringclasses 3
values | cancer_type stringclasses 10
values | icd_o_morphology_code stringclasses 9
values | morphology_description stringclasses 9
values | grade stringclasses 4
values | lymphovascular_invasion stringclasses 3
values | perineural_invasion stringclasses 3
values | margin_status stringclasses 4
values | ihc_er stringclasses 3
values | ihc_pr stringclasses 3
values | ihc_her2 stringclasses 4
values | ihc_ki67_index stringclasses 825
values | ihc_p53 stringclasses 3
values | molecular_subtype stringclasses 4
values | specimen_type stringclasses 4
values | diagnosis_confirmed stringclasses 3
values | turnaround_time_days int64 3 27 | scenario stringclasses 1
value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
PATH-NIG-2019-04301 | Nigeria | 2,019 | District | Lung | 8500/3 | Ductal carcinoma | Poorly differentiated | Absent | Present | Negative | Negative | Positive | Negative | Not done | Negative | null | Core needle biopsy | Yes | 24 | moderate_burden |
PATH-NIG-2022-04302 | Nigeria | 2,022 | Regional | Cervix | 8260/3 | Papillary carcinoma | Moderately differentiated | Not documented | Not documented | Negative | Negative | Negative | Negative | 53.6 | Positive | null | Excisional biopsy | No - inconclusive | 11 | moderate_burden |
PATH-ETH-2025-04303 | Ethiopia | 2,025 | Regional | Bladder | 8070/3 | Squamous cell carcinoma | Poorly differentiated | Not documented | Absent | Positive | Positive | Positive | Positive | Not done | Negative | null | Core needle biopsy | Yes | 3 | moderate_burden |
PATH-SOU-2021-04304 | South Africa | 2,021 | District | Bladder | 8500/3 | Ductal carcinoma | Moderately differentiated | Absent | Absent | Negative | Negative | Positive | Negative | 21.8 | Positive | null | Core needle biopsy | No - suboptimal | 21 | moderate_burden |
PATH-TAN-2019-04305 | Tanzania | 2,019 | Regional | Liver | 8500/3 | Ductal carcinoma | Moderately differentiated | Present | Absent | Positive | Not done | Not done | Negative | 56.4 | Negative | null | Fine needle aspirate | Yes | 27 | moderate_burden |
PATH-UGA-2022-04306 | Uganda | 2,022 | District | Prostate | 8070/3 | Squamous cell carcinoma | Poorly differentiated | Present | Absent | Negative | Positive | Positive | Negative | Not done | Negative | null | Resection | Yes | 10 | moderate_burden |
PATH-TAN-2018-04307 | Tanzania | 2,018 | National referral | Liver | 8500/3 | Ductal carcinoma | Poorly differentiated | Absent | Absent | Negative | Positive | Negative | Negative | 13.9 | Positive | null | Resection | Yes | 24 | moderate_burden |
PATH-KEN-2025-04308 | Kenya | 2,025 | Regional | Thyroid | 8500/3 | Ductal carcinoma | Poorly differentiated | Not documented | Absent | Negative | Positive | Negative | Negative | Not done | Negative | null | Core needle biopsy | Yes | 9 | moderate_burden |
PATH-GHA-2023-04309 | Ghana | 2,023 | Regional | Bladder | 8140/3 | Adenocarcinoma | Moderately differentiated | Present | Not documented | Not applicable | Positive | Positive | Negative | 88.7 | Not done | null | Excisional biopsy | Yes | 24 | moderate_burden |
PATH-SOU-2019-04310 | South Africa | 2,019 | Regional | Thyroid | 8510/3 | Medullary carcinoma | Moderately differentiated | Present | Not documented | Close | Negative | Not done | Negative | 44.8 | Negative | null | Excisional biopsy | No - suboptimal | 7 | moderate_burden |
PATH-UGA-2018-04311 | Uganda | 2,018 | Regional | Colorectal | 8070/3 | Squamous cell carcinoma | Undifferentiated | Present | Not documented | Negative | Positive | Positive | Negative | 13.3 | Negative | null | Core needle biopsy | Yes | 3 | moderate_burden |
PATH-TAN-2025-04312 | Tanzania | 2,025 | National referral | Stomach | 8140/3 | Adenocarcinoma | Poorly differentiated | Not documented | Not documented | Not applicable | Positive | Positive | Positive | 16.1 | Positive | null | Core needle biopsy | Yes | 10 | moderate_burden |
PATH-GHA-2022-04313 | Ghana | 2,022 | National referral | Liver | 8070/3 | Squamous cell carcinoma | Moderately differentiated | Absent | Absent | Negative | Negative | Negative | Equivocal | 25.4 | Negative | null | Core needle biopsy | Yes | 16 | moderate_burden |
PATH-GHA-2018-04314 | Ghana | 2,018 | Regional | Liver | 8140/3 | Adenocarcinoma | Poorly differentiated | Present | Not documented | Negative | Positive | Positive | Equivocal | 7.9 | Not done | null | Excisional biopsy | Yes | 4 | moderate_burden |
PATH-TAN-2023-04315 | Tanzania | 2,023 | National referral | Ovary | 8500/3 | Ductal carcinoma | Poorly differentiated | Absent | Absent | Close | Positive | Negative | Negative | Not done | Negative | null | Fine needle aspirate | Yes | 18 | moderate_burden |
PATH-UGA-2019-04316 | Uganda | 2,019 | District | Cervix | 8070/3 | Squamous cell carcinoma | Undifferentiated | Not documented | Absent | Negative | Positive | Negative | Negative | 45.4 | Negative | null | Fine needle aspirate | Yes | 25 | moderate_burden |
PATH-NIG-2023-04317 | Nigeria | 2,023 | National referral | Colorectal | 8260/3 | Papillary carcinoma | Moderately differentiated | Present | Not documented | Negative | Negative | Negative | Negative | 73.1 | Negative | null | Resection | No - suboptimal | 17 | moderate_burden |
PATH-NIG-2021-04318 | Nigeria | 2,021 | National referral | Breast | 8260/3 | Papillary carcinoma | Moderately differentiated | Absent | Present | Negative | Not done | Positive | Negative | 31.5 | Negative | Triple negative | Core needle biopsy | Yes | 8 | moderate_burden |
PATH-TAN-2025-04319 | Tanzania | 2,025 | National referral | Breast | 8500/3 | Ductal carcinoma | Moderately differentiated | Absent | Not documented | Negative | Positive | Negative | Positive | Not done | Negative | HER2+ | Excisional biopsy | Yes | 13 | moderate_burden |
PATH-GHA-2021-04320 | Ghana | 2,021 | District | Cervix | 8140/3 | Adenocarcinoma | Poorly differentiated | Present | Present | Negative | Not done | Positive | Positive | 31.2 | Positive | null | Core needle biopsy | Yes | 24 | moderate_burden |
PATH-GHA-2023-04321 | Ghana | 2,023 | District | Lung | 8260/3 | Papillary carcinoma | Poorly differentiated | Absent | Present | Negative | Negative | Negative | Negative | 80.7 | Negative | null | Resection | Yes | 25 | moderate_burden |
PATH-SOU-2024-04322 | South Africa | 2,024 | National referral | Ovary | 8140/3 | Adenocarcinoma | Undifferentiated | Not documented | Not documented | Positive | Positive | Negative | Negative | 57.4 | Negative | null | Excisional biopsy | Yes | 26 | moderate_burden |
PATH-TAN-2023-04323 | Tanzania | 2,023 | Regional | Colorectal | 8070/3 | Squamous cell carcinoma | Poorly differentiated | Absent | Present | Positive | Positive | Not done | Negative | Not done | Positive | null | Excisional biopsy | No - inconclusive | 27 | moderate_burden |
PATH-UGA-2023-04324 | Uganda | 2,023 | Regional | Colorectal | 8500/3 | Ductal carcinoma | Well differentiated | Absent | Absent | Close | Negative | Negative | Positive | 58.6 | Negative | null | Core needle biopsy | Yes | 3 | moderate_burden |
PATH-ETH-2024-04325 | Ethiopia | 2,024 | National referral | Lung | 8140/3 | Adenocarcinoma | Undifferentiated | Absent | Absent | Negative | Negative | Negative | Negative | 72.9 | Negative | null | Core needle biopsy | No - inconclusive | 23 | moderate_burden |
PATH-KEN-2018-04326 | Kenya | 2,018 | Regional | Colorectal | 8500/3 | Ductal carcinoma | Well differentiated | Not documented | Absent | Close | Not done | Negative | Negative | Not done | Positive | null | Core needle biopsy | Yes | 4 | moderate_burden |
PATH-GHA-2022-04327 | Ghana | 2,022 | District | Ovary | 8140/3 | Adenocarcinoma | Well differentiated | Absent | Absent | Negative | Negative | Positive | Positive | Not done | Not done | null | Resection | Yes | 9 | moderate_burden |
PATH-SOU-2020-04328 | South Africa | 2,020 | National referral | Cervix | 8140/3 | Adenocarcinoma | Moderately differentiated | Absent | Absent | Not applicable | Positive | Positive | Negative | 86.8 | Positive | null | Core needle biopsy | Yes | 10 | moderate_burden |
PATH-UGA-2022-04329 | Uganda | 2,022 | National referral | Stomach | 8260/3 | Papillary carcinoma | Poorly differentiated | Not documented | Absent | Negative | Positive | Negative | Positive | 63.4 | Negative | null | Fine needle aspirate | No - inconclusive | 11 | moderate_burden |
PATH-UGA-2024-04330 | Uganda | 2,024 | District | Thyroid | 8140/3 | Adenocarcinoma | Moderately differentiated | Present | Absent | Negative | Positive | Negative | Not done | 24.4 | Positive | null | Core needle biopsy | Yes | 20 | moderate_burden |
PATH-ETH-2023-04331 | Ethiopia | 2,023 | District | Liver | 8510/3 | Medullary carcinoma | Moderately differentiated | Not documented | Absent | Negative | Negative | Positive | Negative | Not done | Positive | null | Resection | No - inconclusive | 19 | moderate_burden |
PATH-KEN-2022-04332 | Kenya | 2,022 | Regional | Stomach | 8140/3 | Adenocarcinoma | Poorly differentiated | Absent | Absent | Negative | Negative | Positive | Negative | Not done | Positive | null | Core needle biopsy | No - inconclusive | 15 | moderate_burden |
PATH-TAN-2022-04333 | Tanzania | 2,022 | Regional | Colorectal | 8070/3 | Squamous cell carcinoma | Moderately differentiated | Present | Not documented | Positive | Positive | Positive | Negative | Not done | Negative | null | Core needle biopsy | Yes | 16 | moderate_burden |
PATH-SOU-2022-04334 | South Africa | 2,022 | Regional | Colorectal | 8070/3 | Squamous cell carcinoma | Moderately differentiated | Present | Not documented | Not applicable | Positive | Negative | Positive | 36.2 | Positive | null | Resection | No - inconclusive | 3 | moderate_burden |
PATH-ETH-2023-04335 | Ethiopia | 2,023 | National referral | Prostate | 8500/3 | Ductal carcinoma | Poorly differentiated | Absent | Absent | Negative | Positive | Positive | Negative | 11.5 | Positive | null | Excisional biopsy | No - suboptimal | 20 | moderate_burden |
PATH-GHA-2019-04336 | Ghana | 2,019 | Regional | Stomach | 8140/3 | Adenocarcinoma | Moderately differentiated | Not documented | Not documented | Close | Positive | Negative | Positive | 13.9 | Positive | null | Excisional biopsy | Yes | 21 | moderate_burden |
PATH-SOU-2024-04337 | South Africa | 2,024 | Regional | Ovary | 8140/3 | Adenocarcinoma | Moderately differentiated | Absent | Not documented | Not applicable | Negative | Positive | Negative | Not done | Negative | null | Resection | Yes | 12 | moderate_burden |
PATH-GHA-2018-04338 | Ghana | 2,018 | District | Liver | 8140/3 | Adenocarcinoma | Poorly differentiated | Not documented | Absent | Negative | Not done | Positive | Negative | Not done | Positive | null | Core needle biopsy | Yes | 5 | moderate_burden |
PATH-NIG-2021-04339 | Nigeria | 2,021 | District | Cervix | 8140/3 | Adenocarcinoma | Poorly differentiated | Absent | Not documented | Positive | Positive | Negative | Negative | Not done | Positive | null | Core needle biopsy | No - inconclusive | 26 | moderate_burden |
PATH-ETH-2024-04340 | Ethiopia | 2,024 | Regional | Cervix | 8500/3 | Ductal carcinoma | Poorly differentiated | Present | Not documented | Negative | Not done | Positive | Negative | 18.1 | Not done | null | Core needle biopsy | Yes | 16 | moderate_burden |
PATH-UGA-2025-04341 | Uganda | 2,025 | District | Liver | 8310/3 | Clear cell carcinoma | Poorly differentiated | Not documented | Present | Close | Negative | Negative | Negative | Not done | Negative | null | Core needle biopsy | Yes | 3 | moderate_burden |
PATH-TAN-2019-04342 | Tanzania | 2,019 | Regional | Cervix | 8430/3 | Mucoepidermoid carcinoma | Well differentiated | Present | Absent | Negative | Positive | Positive | Negative | Not done | Not done | null | Resection | Yes | 22 | moderate_burden |
PATH-GHA-2019-04343 | Ghana | 2,019 | District | Colorectal | 8260/3 | Papillary carcinoma | Poorly differentiated | Present | Present | Negative | Positive | Negative | Equivocal | Not done | Negative | null | Core needle biopsy | Yes | 13 | moderate_burden |
PATH-TAN-2021-04344 | Tanzania | 2,021 | Regional | Lung | 8310/3 | Clear cell carcinoma | Moderately differentiated | Absent | Present | Positive | Positive | Positive | Negative | 40.3 | Negative | null | Core needle biopsy | Yes | 6 | moderate_burden |
PATH-ETH-2021-04345 | Ethiopia | 2,021 | National referral | Stomach | 8140/3 | Adenocarcinoma | Moderately differentiated | Absent | Not documented | Negative | Negative | Positive | Negative | 48.4 | Negative | null | Excisional biopsy | Yes | 22 | moderate_burden |
PATH-ETH-2020-04346 | Ethiopia | 2,020 | District | Ovary | 8070/3 | Squamous cell carcinoma | Poorly differentiated | Present | Not documented | Negative | Positive | Negative | Equivocal | Not done | Positive | null | Resection | No - inconclusive | 24 | moderate_burden |
PATH-ETH-2019-04347 | Ethiopia | 2,019 | National referral | Bladder | 8500/3 | Ductal carcinoma | Undifferentiated | Absent | Absent | Negative | Negative | Positive | Not done | 19.2 | Negative | null | Fine needle aspirate | No - inconclusive | 13 | moderate_burden |
PATH-TAN-2019-04348 | Tanzania | 2,019 | District | Prostate | 8070/3 | Squamous cell carcinoma | Moderately differentiated | Present | Not documented | Negative | Negative | Negative | Negative | Not done | Positive | null | Resection | Yes | 16 | moderate_burden |
PATH-SOU-2020-04349 | South Africa | 2,020 | Regional | Stomach | 8720/3 | Melanoma | Moderately differentiated | Absent | Present | Negative | Not done | Positive | Negative | Not done | Positive | null | Core needle biopsy | Yes | 16 | moderate_burden |
PATH-NIG-2022-04350 | Nigeria | 2,022 | District | Lung | 8310/3 | Clear cell carcinoma | Poorly differentiated | Not documented | Absent | Negative | Positive | Negative | Negative | Not done | Positive | null | Resection | Yes | 23 | moderate_burden |
PATH-TAN-2022-04351 | Tanzania | 2,022 | District | Prostate | 8070/3 | Squamous cell carcinoma | Moderately differentiated | Present | Absent | Negative | Negative | Positive | Negative | 85.1 | Positive | null | Excisional biopsy | Yes | 8 | moderate_burden |
PATH-NIG-2022-04352 | Nigeria | 2,022 | National referral | Bladder | 8070/3 | Squamous cell carcinoma | Moderately differentiated | Absent | Absent | Negative | Positive | Positive | Negative | 62.2 | Negative | null | Core needle biopsy | Yes | 18 | moderate_burden |
PATH-UGA-2019-04353 | Uganda | 2,019 | District | Liver | 8500/3 | Ductal carcinoma | Poorly differentiated | Absent | Absent | Close | Negative | Negative | Negative | Not done | Positive | null | Core needle biopsy | No - inconclusive | 18 | moderate_burden |
PATH-TAN-2019-04354 | Tanzania | 2,019 | Regional | Prostate | 8140/3 | Adenocarcinoma | Moderately differentiated | Absent | Absent | Positive | Not done | Negative | Negative | 18.3 | Positive | null | Resection | Yes | 16 | moderate_burden |
PATH-KEN-2024-04355 | Kenya | 2,024 | National referral | Cervix | 8310/3 | Clear cell carcinoma | Moderately differentiated | Present | Absent | Negative | Positive | Negative | Negative | 80.1 | Not done | null | Resection | Yes | 11 | moderate_burden |
PATH-TAN-2020-04356 | Tanzania | 2,020 | District | Bladder | 8310/3 | Clear cell carcinoma | Poorly differentiated | Absent | Absent | Negative | Negative | Negative | Negative | Not done | Positive | null | Core needle biopsy | No - inconclusive | 4 | moderate_burden |
PATH-UGA-2020-04357 | Uganda | 2,020 | Regional | Liver | 8070/3 | Squamous cell carcinoma | Poorly differentiated | Absent | Absent | Negative | Negative | Not done | Positive | 52.8 | Positive | null | Resection | Yes | 15 | moderate_burden |
PATH-KEN-2018-04358 | Kenya | 2,018 | District | Cervix | 8140/3 | Adenocarcinoma | Poorly differentiated | Absent | Not documented | Negative | Negative | Not done | Negative | Not done | Positive | null | Core needle biopsy | Yes | 18 | moderate_burden |
PATH-GHA-2018-04359 | Ghana | 2,018 | District | Ovary | 8720/3 | Melanoma | Moderately differentiated | Absent | Absent | Negative | Negative | Positive | Negative | 42.6 | Positive | null | Resection | Yes | 22 | moderate_burden |
PATH-NIG-2025-04360 | Nigeria | 2,025 | Regional | Liver | 8070/3 | Squamous cell carcinoma | Poorly differentiated | Absent | Not documented | Negative | Positive | Positive | Positive | 62.7 | Negative | null | Excisional biopsy | Yes | 10 | moderate_burden |
PATH-GHA-2022-04361 | Ghana | 2,022 | Regional | Stomach | 8140/3 | Adenocarcinoma | Moderately differentiated | Present | Not documented | Negative | Positive | Positive | Positive | 31.3 | Positive | null | Excisional biopsy | Yes | 3 | moderate_burden |
PATH-KEN-2020-04362 | Kenya | 2,020 | National referral | Prostate | 8510/3 | Medullary carcinoma | Poorly differentiated | Not documented | Not documented | Negative | Positive | Positive | Negative | 13.2 | Negative | null | Core needle biopsy | Yes | 22 | moderate_burden |
PATH-SOU-2018-04363 | South Africa | 2,018 | National referral | Prostate | 8500/3 | Ductal carcinoma | Undifferentiated | Absent | Not documented | Positive | Positive | Negative | Negative | 52.2 | Negative | null | Core needle biopsy | Yes | 19 | moderate_burden |
PATH-TAN-2024-04364 | Tanzania | 2,024 | District | Thyroid | 8140/3 | Adenocarcinoma | Moderately differentiated | Absent | Absent | Negative | Not done | Negative | Negative | Not done | Positive | null | Core needle biopsy | Yes | 18 | moderate_burden |
PATH-ETH-2018-04365 | Ethiopia | 2,018 | Regional | Lung | 8140/3 | Adenocarcinoma | Well differentiated | Absent | Absent | Positive | Negative | Positive | Positive | 15.2 | Negative | null | Core needle biopsy | Yes | 17 | moderate_burden |
PATH-UGA-2023-04366 | Uganda | 2,023 | District | Colorectal | 8500/3 | Ductal carcinoma | Moderately differentiated | Absent | Absent | Negative | Positive | Positive | Negative | 11.0 | Not done | null | Core needle biopsy | Yes | 22 | moderate_burden |
PATH-KEN-2024-04367 | Kenya | 2,024 | Regional | Cervix | 8140/3 | Adenocarcinoma | Well differentiated | Absent | Absent | Negative | Negative | Positive | Positive | Not done | Negative | null | Resection | No - inconclusive | 14 | moderate_burden |
PATH-TAN-2025-04368 | Tanzania | 2,025 | Regional | Cervix | 8510/3 | Medullary carcinoma | Poorly differentiated | Absent | Not documented | Negative | Positive | Not done | Negative | 21.1 | Negative | null | Core needle biopsy | Yes | 6 | moderate_burden |
PATH-GHA-2021-04369 | Ghana | 2,021 | Regional | Prostate | 8070/3 | Squamous cell carcinoma | Poorly differentiated | Absent | Present | Negative | Positive | Positive | Positive | 26.8 | Negative | null | Excisional biopsy | Yes | 16 | moderate_burden |
PATH-SOU-2020-04370 | South Africa | 2,020 | Regional | Ovary | 8430/3 | Mucoepidermoid carcinoma | Poorly differentiated | Present | Absent | Negative | Positive | Positive | Negative | 34.3 | Positive | null | Core needle biopsy | Yes | 3 | moderate_burden |
PATH-TAN-2019-04371 | Tanzania | 2,019 | Regional | Lung | 8890/3 | Leiomyosarcoma | Poorly differentiated | Absent | Not documented | Negative | Negative | Positive | Equivocal | 14.6 | Positive | null | Resection | Yes | 13 | moderate_burden |
PATH-UGA-2024-04372 | Uganda | 2,024 | District | Prostate | 8140/3 | Adenocarcinoma | Undifferentiated | Absent | Absent | Negative | Positive | Positive | Positive | 67.2 | Negative | null | Excisional biopsy | Yes | 8 | moderate_burden |
PATH-ETH-2024-04373 | Ethiopia | 2,024 | District | Lung | 8140/3 | Adenocarcinoma | Moderately differentiated | Not documented | Present | Negative | Positive | Negative | Negative | 64.1 | Positive | null | Excisional biopsy | Yes | 19 | moderate_burden |
PATH-TAN-2020-04374 | Tanzania | 2,020 | National referral | Liver | 8140/3 | Adenocarcinoma | Well differentiated | Absent | Not documented | Negative | Negative | Positive | Negative | 87.7 | Negative | null | Excisional biopsy | Yes | 13 | moderate_burden |
PATH-SOU-2022-04375 | South Africa | 2,022 | National referral | Breast | 8140/3 | Adenocarcinoma | Poorly differentiated | Present | Absent | Positive | Positive | Negative | Negative | 24.5 | Positive | Luminal A | Core needle biopsy | Yes | 22 | moderate_burden |
PATH-TAN-2018-04376 | Tanzania | 2,018 | National referral | Cervix | 8500/3 | Ductal carcinoma | Poorly differentiated | Present | Not documented | Negative | Negative | Not done | Negative | 89.4 | Positive | null | Fine needle aspirate | Yes | 14 | moderate_burden |
PATH-GHA-2023-04377 | Ghana | 2,023 | District | Thyroid | 8500/3 | Ductal carcinoma | Moderately differentiated | Not documented | Absent | Close | Positive | Not done | Negative | 38.9 | Negative | null | Core needle biopsy | Yes | 10 | moderate_burden |
PATH-NIG-2018-04378 | Nigeria | 2,018 | District | Liver | 8430/3 | Mucoepidermoid carcinoma | Moderately differentiated | Absent | Absent | Negative | Negative | Negative | Positive | Not done | Not done | null | Resection | No - suboptimal | 27 | moderate_burden |
PATH-NIG-2019-04379 | Nigeria | 2,019 | District | Thyroid | 8140/3 | Adenocarcinoma | Poorly differentiated | Absent | Not documented | Negative | Positive | Not done | Negative | 53.7 | Negative | null | Excisional biopsy | No - inconclusive | 14 | moderate_burden |
PATH-KEN-2023-04380 | Kenya | 2,023 | Regional | Lung | 8070/3 | Squamous cell carcinoma | Undifferentiated | Absent | Absent | Negative | Positive | Negative | Negative | 78.5 | Positive | null | Core needle biopsy | Yes | 13 | moderate_burden |
PATH-KEN-2021-04381 | Kenya | 2,021 | National referral | Cervix | 8140/3 | Adenocarcinoma | Poorly differentiated | Absent | Absent | Negative | Negative | Positive | Negative | 63.6 | Positive | null | Fine needle aspirate | Yes | 9 | moderate_burden |
PATH-TAN-2022-04382 | Tanzania | 2,022 | District | Stomach | 8140/3 | Adenocarcinoma | Poorly differentiated | Absent | Absent | Positive | Positive | Negative | Negative | 8.8 | Negative | null | Fine needle aspirate | No - inconclusive | 14 | moderate_burden |
PATH-TAN-2019-04383 | Tanzania | 2,019 | District | Cervix | 8140/3 | Adenocarcinoma | Poorly differentiated | Not documented | Present | Negative | Negative | Negative | Negative | Not done | Positive | null | Core needle biopsy | No - inconclusive | 9 | moderate_burden |
PATH-KEN-2025-04384 | Kenya | 2,025 | National referral | Ovary | 8070/3 | Squamous cell carcinoma | Poorly differentiated | Absent | Not documented | Negative | Not done | Positive | Negative | 84.1 | Positive | null | Resection | Yes | 9 | moderate_burden |
PATH-SOU-2021-04385 | South Africa | 2,021 | District | Cervix | 8070/3 | Squamous cell carcinoma | Well differentiated | Present | Not documented | Negative | Negative | Positive | Negative | Not done | Positive | null | Core needle biopsy | Yes | 23 | moderate_burden |
PATH-NIG-2024-04386 | Nigeria | 2,024 | Regional | Ovary | 8070/3 | Squamous cell carcinoma | Undifferentiated | Not documented | Present | Not applicable | Positive | Positive | Negative | 80.9 | Positive | null | Core needle biopsy | Yes | 18 | moderate_burden |
PATH-TAN-2025-04387 | Tanzania | 2,025 | District | Bladder | 8500/3 | Ductal carcinoma | Moderately differentiated | Absent | Not documented | Positive | Negative | Not done | Negative | Not done | Positive | null | Core needle biopsy | Yes | 14 | moderate_burden |
PATH-SOU-2022-04388 | South Africa | 2,022 | National referral | Prostate | 8500/3 | Ductal carcinoma | Poorly differentiated | Present | Not documented | Negative | Not done | Positive | Positive | 12.4 | Positive | null | Resection | Yes | 24 | moderate_burden |
PATH-GHA-2018-04389 | Ghana | 2,018 | Regional | Prostate | 8500/3 | Ductal carcinoma | Poorly differentiated | Not documented | Absent | Negative | Negative | Negative | Positive | 44.3 | Positive | null | Resection | Yes | 15 | moderate_burden |
PATH-SOU-2018-04390 | South Africa | 2,018 | District | Cervix | 8140/3 | Adenocarcinoma | Poorly differentiated | Not documented | Not documented | Negative | Positive | Positive | Negative | Not done | Positive | null | Core needle biopsy | Yes | 9 | moderate_burden |
PATH-TAN-2025-04391 | Tanzania | 2,025 | District | Prostate | 8140/3 | Adenocarcinoma | Undifferentiated | Present | Not documented | Negative | Negative | Positive | Negative | Not done | Not done | null | Core needle biopsy | Yes | 23 | moderate_burden |
PATH-KEN-2021-04392 | Kenya | 2,021 | District | Cervix | 8070/3 | Squamous cell carcinoma | Poorly differentiated | Absent | Not documented | Close | Positive | Negative | Positive | 70.0 | Not done | null | Excisional biopsy | Yes | 5 | moderate_burden |
PATH-ETH-2025-04393 | Ethiopia | 2,025 | Regional | Lung | 8260/3 | Papillary carcinoma | Poorly differentiated | Not documented | Not documented | Not applicable | Not done | Positive | Not done | 22.8 | Positive | null | Fine needle aspirate | Yes | 26 | moderate_burden |
PATH-GHA-2023-04394 | Ghana | 2,023 | Regional | Colorectal | 8070/3 | Squamous cell carcinoma | Poorly differentiated | Present | Present | Negative | Positive | Positive | Positive | 82.4 | Negative | null | Excisional biopsy | Yes | 3 | moderate_burden |
PATH-ETH-2020-04395 | Ethiopia | 2,020 | National referral | Ovary | 8140/3 | Adenocarcinoma | Moderately differentiated | Not documented | Present | Negative | Negative | Not done | Negative | 58.3 | Not done | null | Resection | No - inconclusive | 16 | moderate_burden |
PATH-KEN-2023-04396 | Kenya | 2,023 | Regional | Breast | 8140/3 | Adenocarcinoma | Well differentiated | Absent | Present | Positive | Positive | Positive | Negative | Not done | Positive | Luminal A | Core needle biopsy | Yes | 16 | moderate_burden |
PATH-SOU-2023-04397 | South Africa | 2,023 | Regional | Thyroid | 8500/3 | Ductal carcinoma | Poorly differentiated | Absent | Absent | Positive | Positive | Positive | Negative | 44.2 | Positive | null | Excisional biopsy | Yes | 3 | moderate_burden |
PATH-KEN-2025-04398 | Kenya | 2,025 | National referral | Ovary | 8140/3 | Adenocarcinoma | Moderately differentiated | Absent | Absent | Negative | Positive | Negative | Negative | 83.8 | Positive | null | Core needle biopsy | Yes | 19 | moderate_burden |
PATH-ETH-2022-04399 | Ethiopia | 2,022 | Regional | Liver | 8140/3 | Adenocarcinoma | Poorly differentiated | Absent | Not documented | Negative | Negative | Positive | Negative | 36.2 | Positive | null | Core needle biopsy | Yes | 3 | moderate_burden |
PATH-GHA-2025-04400 | Ghana | 2,025 | Regional | Breast | 8500/3 | Ductal carcinoma | Undifferentiated | Absent | Absent | Negative | Positive | Negative | Negative | 8.3 | Negative | Triple negative | Excisional biopsy | Yes | 7 | moderate_burden |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.